Sort
141,003 grants matching “cytokine”
In vivo mechanisms mediating sickle cell vaso-occlusion and organ damage
$583,081Libusha Kelly · Albert Einstein College Of Medicine · R01 · FY2021 · HL
Surgery to Prevent Post Infarction Ventricular Remodeling
$583,074Robert C Gorman · University Of Pennsylvania · R01 · FY2015 · HL
PD-1 modulation of SIV specific CD4 and CD8 T cell responses
$582,964Francois J Villinger · Emory University · R01 · FY2009 · AI
Pathways of Maternal Anemia
$582,954Michal Fried Fried · Seattle Biomedical Research Institute · R01 · FY2010 · HD
Elucidating the path to type I IFNs in TB infection
$582,940Amy K Barczak · Massachusetts General Hospital · R01 · FY2021 · AI
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy.
$582,940Mary L. Disis · University Of Washington · R01 · FY2009 · CA
Maternal Obesity and Pediatric NAFLD: Fetal Origins and Long-term outcomes in Non Human Primates
$582,919Jacob E Friedman · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2022 · DK
Functional outcomes of inflammatory bowel disease associated variants
$582,900Clara Abraham · Yale University · R01 · FY2019 · DK
Discovery and development of potent inhibitors of Jun N-terminal kinase for non-hormonal treatment of endometriosis and associated pain
$582,885Stephen Sunderland Palmer · Baylor College Of Medicine · R01 · FY2022 · HD
Probing Osteoarthritis Pathogenesis by Noninvasive Imaging of Cartilage Strain
$582,873Corey P Neu · University Of Colorado · R01 · FY2023 · AR
Role of IRF2 in cancer immune evasion and immunotherapy
$582,872Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · CA
Role of IRF2 in cancer immune evasion and immunotherapy
$582,872Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · CA
Eltrombopag for the Treatment of Bone Marrow Failure Syndromes
$582,866Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Sex and gender differences in lupus - intersection between immunometabolism, epigenetic remodeling and cardiac involvement
$582,863Caroline Jefferies · Cedars-Sinai Medical Center · R01 · FY2023 · AI
Hyperglycemia mediated myeloproliferative disease
$582,811Reuben Kapur · Indiana University Indianapolis · R01 · FY2022 · HL
Hyperglycemia mediated myeloproliferative disease
$582,811Reuben Kapur · Indiana University Indianapolis · R01 · FY2021 · HL
Cellular and humoral immunity in Lyme arthritis
$582,807Allen C Steere · Massachusetts General Hospital · R01 · FY2022 · AI
Cellular and humoral immunity in Lyme arthritis
$582,807Allen C Steere · Massachusetts General Hospital · R01 · FY2023 · AI
Cellular and humoral immunity in Lyme arthritis
$582,807Allen C Steere · Massachusetts General Hospital · R01 · FY2019 · AI
Cellular and humoral immunity in Lyme arthritis
$582,807Allen C Steere · Massachusetts General Hospital · R01 · FY2021 · AI
Cellular and humoral immunity in Lyme arthritis
$582,807Allen C Steere · Massachusetts General Hospital · R01 · FY2020 · AI
Antiviral activity of Peg-IFN alpha in chronic HIV-1
$582,803Luis J. Montaner · Wistar Institute · U01 · FY2008 · AI
Education of the fetal immune system by inherited maternal cells
$582,785Whitney Elizabeth Harrington · Seattle Children'S Hospital · R01 · FY2023 · AI
Lung epithelial cell-derived C3 in acute lung injury
$582,781Hrishikesh Satish Kulkarni · Washington University · R01 · FY2024 · HL
Targeting T2 inflammation-evoked mechanical endotypes of ASM shortening in asthma
$582,771Steven S An · Rutgers Biomedical And Health Sciences · R01 · FY2023 · HL